August 23, 2018
Joint Commission revises requirements for medication compounding
Editor's Note
The Joint Commission announced on August 22 that several revisions will be implemented to the Medication Compounding Certification program and Home Care Accreditation program’s Medication Compounding chapter, effective January 1, 2019.
The revisions were made to maintain consistency with current United States Pharmacopeia (USP) 795 (Pharmaceutical Compounding−Nonsterile Preparations) and USP 797 (Pharmaceutical Compounding−Sterile Preparations) requirements.
Free Daily News
- Take the OR Manager Career/Salary Survey, help shape the future of perioperative leadership
- Virtual care, tech-enabled roles reshape nursing as leaders diverge on care redesign priorities
- As healthcare faces skyrocketing cyberattacks, surgeons are urged to lead frontline defense
- Study shows WHO surgical checklist boosts safety, but compliance gaps risk patient outcomes
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
- Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients
- Same-day discharge after catheter ablation gains backing from top cardiology societies
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement